Article thumbnail

Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients

By A. E. Frankel, J. H. Woo, C. Ahn, N. Pemmaraju, B. C. Medeiros, H. E. Carraway, O. Frankfurt, S. J. Forman, X. A. Yang, M. Konopleva, F. Garnache-Ottou, F. Angelot-Delettre, C. Brooks, M. Szarek and E. Rowinsky
Publisher: American Society of Hematology
Year: 2014
DOI identifier: 10.1182/blood-2014-04-566737
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.